Larry Liang Wang

Larry Liang Wang is a Clinical Professor of Pathology at the University of Southern California, affiliated with Children’s Hospital Los Angeles (CHLA). His work focuses on pediatric pathology, particularly in oncologic and molecular diagnostics. He holds an MD and PhD, specializing in the intersection of clinical practice and research.

Research interests include neuroblastoma biology, hepatoblastoma genetics, pediatric liver diseases, and the molecular mechanisms underlying pediatric tumors. He has contributed extensively to diagnostic standards for peripheral neuroblastic tumors and genomic characterization of mesenchymal tumors.

Publications span over two decades, emphasizing tumor classification (e.g., hepatocellular neoplasms), immunohistochemical markers (e.g., Phox2b staining for Hirschsprung disease), and translational research (e.g., NK cell-based immunotherapy for neuroblastoma).

No awards or grants are explicitly listed, but his contributions to pediatric pathology are evident through his prolific publication record and collaborative projects like the International Collaboration on Cancer Reporting (ICCR).

Labs/teams: Collaborates with institutions such as Children’s Oncology Group and the International Neuroblastoma Pathology Committee. His work integrates morphologic, genomic, and clinical data for improved pediatric tumor diagnosis and treatment strategies.